-+ 0.00%
-+ 0.00%
-+ 0.00%

Nextbiomedical Corrects 2025 R&D Costs to KRW 8.01 Billion

PUBT·11/19/2026 05:54:47
Listen to the news
Nextbiomedical Corrects 2025 R&D Costs to KRW 8.01 Billion
  • Nextbiomedical issued a correction on Nov. 19 to its first-quarter 2026 report, citing clerical errors.
  • Total 2025 research and development costs were revised to KRW 8.01 billion from KRW 8 billion.
  • The carrying value of one property pledged to Woori Bank fell to KRW 9.01 billion from KRW 9.04 billion.
  • A second pledged property's carrying value decreased to KRW 1.24 billion from KRW 1.25 billion; collateral amounts were unchanged.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nextbiomedical Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261119000181), on November 19, 2026, and is solely responsible for the information contained therein.